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Leber congenital amaurosis (LCA) and juvenile retinitis pigmentosa (RP) are themost commonhereditary causes of visual impairment in
infants and children. Using homozygosity mapping, we narrowed down the critical region of the LCA3 locus to 3.8Mb betweenmarkers
D14S1022 and D14S1005. By direct Sanger sequencing of all genes within this region, we found a homozygous nonsense mutation in
the SPATA7 gene in Saudi Arabian family KKESH-060. Three other loss-of-function mutations were subsequently discovered in patients
with LCA or juvenile RP from distinct populations. Furthermore, we determined that Spata7 is expressed in thematuremouse retina. Our
ﬁndings reveal another human visual-disease gene that causes LCA and juvenile RP.Introduction
Leber congenital amaurosis (LCA [MIM 204000]) is a set of
inherited, early-onset retinal dystrophies that affect
approximately 1:50,000 people in the general U.S. popula-
tion and account for more than 5% of all retinal dystro-
phies.1,2 The clinical phenotypes of LCA are characterized
by severe visual loss at birth, nystagmus, a variety of
fundus changes, and minimal or absent recordable
responses on the electroretinogram (ERG), usually with
an autosomal-recessive pattern of inheritance.3 Consistent
with this clinical variability, the molecular basis for LCA is
also heterogeneous, with mutations described in fourteen
genes. Functional studies of previously identiﬁed genes
indicate that they act in strikingly diverse functional path-
ways underlying the disease, including retina development
(CRB1 [MIM 604210],4CRX [MIM602225]5–7), phototrans-
duction (GUCY2D [MIM 600179],8 AIPL1 [MIM 604392]9),
vitamin A metabolism (RPE65 [MIM 180069],10,11 LRAT
[MIM 604863],12 RDH12 [MIM 608830]13), and cilium
formation and function (CEP290 [MIM 610142],14 TULP1
[MIM 602280],15 RPGRIP1 [MIM 605446],16,17 LCA5 [MIM
611408]18). In addition, the function of RD3 remains
unclear.19 Because of these profound differences in the
underlying mechanisms of LCA, accurate molecular diag-
nosis of the disease is essential for the proper management
of LCApatients. Therefore, identifyingnewgenes andpath-
ways andascertaining the full complementof genes respon-
sible for LCA are fundamental steps toward developing
appropriate treatments for this devastating disease.
Knowledge obtained from LCA studies also offers
insights into the pathogenesis and the molecular mecha-
nisms underlying other retinal dystrophies, which are
often shared.20 LCA shares several important clinical380 The American Journal of Human Genetics 84, 380–387, March 1features with other retinal dystrophies, such as retinitis
pigmentosa (RP [MIM 500004]). In fact, LCA was ﬁrst
described as an ‘‘intrauterine’’ form of RP.1 Juvenile RP,
unlike LCA, initially has a milder phenotype. It is often
characterized by the onset of nyctalopia (night blindness),
visual-ﬁeld narrowing, and eventual visual-acuity loss,
with or without nystagmus. Given the substantial clinical
overlap with juvenile RP, it is expected that these two
diseases might be caused by mutations in the same
gene.21 Indeed, at least seven of the known LCA disease
genes, including CRX, CRB1, RPE65, RDH12, LRAT,
MERTK, and TULP1, have also been linked to the clinical
appearance of juvenile RP in other families.22 Similarly,
mutations in LCA genes may also be associated with other
retinal diseases, such as cone-rod dystrophy (CRX,5
AIPL1,23 and GUCY2D8,9), and even systemic diseases,
such as Joubert syndrome, Meckel syndrome, and Bardet-
Biedl syndrome (CEP29024–26).
In addition to these 14 LCA genes, two genetic loci (LCA3
at 14q24 and LCA9 at 1p36) have been identiﬁed, but the
underlying genes remain unknown.27,28 The exclusion of
RDH12 as anLCA3diseasegene suggests that another retinal
dystrophy disease gene is responsible for the LCA3 pheno-
type.29 In this report, we identiﬁed ﬁve new families that
we mapped to the LCA3 locus, utilizing ﬁne mapping of
the critical region through homozygosity mapping and
single-nucleotide polymorphism (SNP) microarray tech-
nology.21 We identiﬁed homozygous nonsense and frame-
shiftmutations inapositional candidategene, SPATA7 (sper-
matogenesis associated protein 7 [MIM 609868]) by direct
Sanger sequencing. SPATA7 encodes a highly conserved
protein containing a single transmembrane domain. To
better understand its normal function in the retina, we
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and mature mouse retina, and we found that it is expressed
in multiple retinal layers in the adult mouse retina.
Subjects and Methods
Study Subjects
We obtained blood samples and pedigrees after receiving informed
consent from all individuals. Approval was obtained from the
Institutional Review Boards of the participating centers. LCA fami-
lies KKESH-019 and KKESH-060 were obtained by R.A.L. through
the King Khaled Eye Specialist Hospital (KKESH) in Riyadh, Saudi
Arabia. Blood samples were collected from all available family
members, and DNA was extracted with the QIAGEN blood
genomic DNA extraction kit, in accordance with the protocol
provided by themanufacturer. Other LCA and juvenile RP samples
were collected at the McGill University Health Center in Montreal
or at the Department of Ophthalmology at the Radboud Univer-
sity Nijmegen Medical Centre in Nijmegen.
STR and SNP Genotyping and Sequencing
A list of microsatellite markers between D14S61 and D14S1015
were selected from the UCSC Human Genome Browser. For geno-
typing, primers speciﬁc for each marker were obtained from the
human genome, and a universal tail was added to the 50 primer
(50-CTCGGTGCAGAGCATCATGC). PCR reactions were per-
formed according to a standard protocol,30 and products were
size fractionated on an ABI 3700 capillary electrophoresis system
and analyzed with the ABI GeneMapping software. A genome-
wide scan of >318,000 tag SNPs was conducted on one affected
member from the KKESH-060 and KKESH-019 families with the
Illumina Hap300-Duo Bead Arrays, in accordance with the manu-
facturer’s protocols. Homozygous regions were visualized and
identiﬁed with the Bead Studio software package.
For identiﬁcation of mutations in candidate genes, a direct PCR-
sequencing approachwas used. All exons and their splice junctions
for each candidate gene (total of 9) in the critical LCA3 regionwere
ampliﬁed by PCR. The completeness and quality of the sequence
was ensured by the design of primers from intron sequences so
that the entire exon and at least 50 bp of intron DNA on each
side of each exon were ampliﬁed for detection of potential muta-
tions. For large exons,more thanonepairofprimers ampliﬁedover-
lapping regions spanning both the exon and its splice sites.
Sequences for the primers of the 12 exons and splice junctions of
SPATA7 are included in Table S1 (available online).
Homozygosity Mapping with SNP Arrays
for Identiﬁcation of LCA and Juvenile RP Patients
Whose Disease Region Overlaps with LCA3
We previously performed homozygosity mapping in 33 consan-
guineous and 60 nonconsanguineous individuals with LCA or
juvenile RP from various ethnic origins with 10K, 100K, or 250K
Affymetrix SNP microarrays,21 and we recently added 50 patients
to this analysis (A.I.d.H., unpublished data). Five patients were
found to be homozygous at the LCA3 locus, with homozygous
regions ranging in size from 1.6 to 29 Mb.
RNA In Situ Hybridization
and Immunohistochemistry
An RNA in situ probe speciﬁc to Spata7 (exons 8–12) was prepared
according to a previously published protocol31 (probe 50-primer:The Ame50-CTAATTACACGAGAAATGGTGCTG; probe 30-primer: 50-AGT
GATGTGCTCAGACAACAGAGT). Total RNA was extracted from
freshly isolated C57 wild-type (WT) eyes homogenized in Trizol
(Invitrogen) and puriﬁed according to the manufacturer’s instruc-
tions. A Spata7 cDNA fragment was cloned into the EcoRI site of
the TOPO cloning vector (Invitrogen). Antisense riboprobe
constructs were linearized with XhoI and transcribed with SP6
RNA polymerase (DIG RNA Labeling Kit, Roche).
RNA in situ hybridization (ISH) and antibody staining was con-
ducted onWT E16.5, P4, and P21 and C57Bl/6 129SvEv F1 hybrid
eye sections. WT eyes were collected, ﬁxed in 4% paraformalde-
hyde overnight, dehydrated in ethanol, and parafﬁn embedded.
For ISH, 5 mm eye sections were cut, dewaxed in xylene, then rehy-
drated and treated with proteinase K. Hybridization incubations
were carried out in hybridization buffer (50% formamide, 5XSSC
[pH 4.5–5.0], 1% SDS, 50 mg/ml yeast tRNA, 50 mg/ml heparin)
at 65C overnight, followed by three 30-min washes with pre-
warmed washing buffer (50% formamide, 1XSSC [pH 4.5–5.0],
1% SDS) at 65C. The slides were then incubated with alkaline
phosphatase-conjugated anti-DIG (Roche) in 13 MABT (100 mM
maleic acid, 150 mM NaCl, 0.1% Tween 20, pH 7.5), 2% BRB
(Roche) and 10% goat serum overnight at room temperature. After
ﬁve washes (30 min each) with MABT buffer and one wash with
NTMT (100 mM Tris-HCl [pH 9.5], 100 mM NaCl, 50 mM
MgCl2, 0.1% Tween 20, and 0.048% levamisole), hybridization
signals were visualized by incubation with BM Purple (Roche) at
room temperature for the desired time.
For immunohistochemistry (IHC), antigen retrieval was per-
formed by boiling of 10 mm sections in 0.01 M citrate buffer twice
for 2 min, followed by cooling for 40 min at room temperature.
Slides were washed in PBS, incubated for 1 hr at room temperature
in hybridization buffer (10% normal goat serum, 0.1% Triton
X-100, PBS), then incubated overnight in primary antibody
diluted in hybridization buffer. Slides were then washed in PBS,
incubated with secondary antibody diluted in hybridization buffer
at room temperature for 2 hr, washed in PBS, and coverslipped. For
testing the speciﬁcity of the Spata7 antibody, a blocking experi-
ment was performed. A GST-Spata7 fusion proteinwas constructed
by insertion of a mouse Spata7 open reading frame into the
multiple cloning site of the pGEX-4T-1 vector. The fusion protein
was induced in the presence of 0.5 mM IPTG at 26C for 8 hr and
puriﬁed with the use of Glutathione Sepharose 4B as described in
manufacturers’ instructions (Amersham Bioscience). The in vitro
antibody-depletion experiments were performed with puriﬁed
GST or GST-Spata7 fusion proteins bound to Glutathione Sephar-
ose 4B. Spata7 antibody was incubated with 50 ml of GST beads,
containing either GST-Spata7 or GST, at 4C overnight, then the
depleted antibody was used for IHC as described above.
Dilutions and sources of antibodies were: mouse anti-rhodopsin
(B6-30N) (1:100, a generous gift from W. Clay Smith), rabbit anti-
Spata7 (1:7.5, Proteintech Group), Alexa anti-mouse (1:400,
Molecular Probes), Cy5 anti-rabbit (1:400, Jackson Immunochem-
icals). Fluorescent images were captured with a Zeiss LSM 510
confocal microscope and processed with Image J and Adobe Pho-
toshop software.
Results
Fine Mapping of the LCA3 Locus
Previously, the LCA3 locus was mapped to chromosome
14q24 in a large, consanguineous LCA family (KKESH-019)rican Journal of Human Genetics 84, 380–387, March 13, 2009 381
Figure 1. Mutations in SPATA7 Cause LCA
(A) The LCA3 critical interval at 14q31. Nine candidate genes within the region are indicated as black bars. SPATA7 is indicated by a black
arrow. The chromosome band is modified on the basis of the Ensemble ContigView.
(B) Exon-intron structure of the SPATA7 gene is shown. Open boxes represent 50 and 30 UTRs, and solid boxes represent coding exons. A
transmembrane domain (TM) is predicted to be encoded in exon 4. Mutations are indicated with arrows.382 The American Journal of Human Genetics 84, 380–387, March 13, 2009
from Saudi Arabia with 15 affected and 42 unaffected
members.27 The critical region was initially identiﬁed by
homozygosity mapping with STR markers. However, the
distal boundary of the critical region was not well mapped,
because there was no genotyping within a 10 Mb segment
between D14S74 and D14S68. More importantly, at least
four recombinants have been reported for marker
D14S68, indicating that the critical region could be greatly
reduced by genotyping of additional markers within the
distal region.
We therefore conducted ﬁne mapping of the distal
boundary of the critical region with additional STR
markers between D14S74 and D14S68 (Table S1). On the
basis of these genotyping results, all affected members of
KKESH-019 were found to be homozygous between
markers D14S1022 and D14S1005 (Figure S1). We then
used these STR markers to scan additional LCA patient
cohorts for new LCA families that may map to the LCA3
region. In this manner, the KKESH-060 family from Saudi
Arabia was also identiﬁed as an LCA3 family29
(Figure S2). All three affected members from the KKESH-
060 family are homozygous from markers D14S61 to
D14S1066. To further conﬁrm the homozygous region,
DNA from one affected subject from each of these two
families was genotyped by whole-genome SNP analysis
with the Illumina SNP array. The new SNP genotyping
results are consistent with the previous STR genotyping
data, and affected subjects from these two families are
homozygous for the LCA3 locus at Chromosome 14q24
(Figure S3). Intersection of the homozygous region from
these two LCA families deﬁnes a critical region of 3.8 Mb
between markers D14S1022 and D14S1005.
SPATA7 Is Another LCA and Juvenile RP Gene
A total of nine annotated genes are included within the
newly deﬁned LCA3 critical region based on NCBI Build
36.1 (Figure 1A). Direct Sanger sequencing of all exons of
all nine candidate genes from both LCA3 families identi-
ﬁed a nonsensemutation in SPATA7, a conserved gene con-
taining 12 exons, in the KKESH-060 family (Figure 1C). All
three affected members of KKESH-060 are homozygous for
a nonsense mutation in the ﬁfth exon (c.322C/T;
p.R108X). The mutation segregates with the disease in
this family, given that the three affected individuals are
homozygous for the same mutation whereas the unaf-
fected members are either heterozygous or do not carry
the mutation (Figure 1C and Figure S2). Furthermore, the
nonsense mutation is not a common SNP, because it is
not recorded in the dbSNP database. Consistent with the
above information, the mutation was not detected in 150
normal control samples, including 50 Saudi Arabian and(p.R395X); patient no. 1348, c.1546delA (p.Q465fsX505).
The Ame100 European samples, through direct sequencing of all
exons of SPATA7 (data not shown). No exonic mutation
was found in KKESH-019 (see Discussion for details). To
further conﬁrm that SPATA7 is an LCA disease gene, we
sought to identify additional LCA patients with SPATA7
mutations. By homozygosity mapping with genome-wide
SNPmicroarrays, ﬁve additional patients with LCA or juve-
nile RP were recently found to be homozygous at the LCA3
locus (21 and unpublished data). Mutation analysis of
SPATA7 revealed the same R108X nonsense mutation
(found in the KKESH-060 family) in a Dutch LCA patient
(no. 12811) (Figure 1C). On the basis of the STR genotyp-
ing result, the mutation analysis suggests that patient no.
12811 does not share the same haplotype with the patients
from KKESH-060 (data not shown). This may be caused by
a rapid decay of CpG sites, given that the 5-methylcytosine
at CpG sites mutates unidirectionally to thymine by spon-
taneous deamination at a much higher transition rate
compared to non-CpG dinucleotides.32 Finally, a homozy-
gous frameshift mutation (c.961dupA; p.P321TfsX326) in
exon 8 of SPATA7 was found in an LCA patient (no. 1617)
of Middle Eastern origin (Figure 1C). In addition, a Portu-
guese patient (no. 28608) with juvenile RP was found to
be homozygous for a nonsense mutation (c.1183C/T;
p.R395X) in exon11of SPATA7 (Figure 1D). Finally, ahomo-
zygous frameshift mutation in exon 12 (c.1546delA;
p.Q465fsX505)was identiﬁed in a FrenchCanadian patient
(no. 1348)with juvenileRP (Figure1D).Allmutations segre-
gated with the disease in the affected families were not
found in the 150 normal controls or in the SNP databases.
In contrast to the two SPATA7mutations identiﬁed in LCA
patients (p.R108X and p.P321TfsX326), the two juvenile
RPmutations are close to the C-terminal part of the SPATA7
protein.
Although carrying mutations in the same gene, the two
juvenile RP patients present a clinical phenotype that is
less severe than that of LCA patients. All three LCA
patients from the KKESH-060 family showed poor visual
ﬁxation and function from birth and subsequently devel-
oped nystagmus, hyperopic astigmatism, and a nondetect-
able electroretinogram. A Dutch patient (no. 12811) was
ﬁrst seen in our clinic at age 6. She has had visual problems
since birth, showing rotating nystagmus, peripheral
chorio-retinal atrophy, and bone spicules pigmentation.
In contrast, a 7-year-old Portuguese girl (no. 28608,
diagnosed with juvenile RP) has excellent visual acuity
(20/20), and nystagmus is absent. She developed early-
onset nyctalopia before age 2 and has 5 visual ﬁelds (Gold-
mann) and nondetectable ERGs (Figure 2A). Similarly,
a juvenile RP patient (no. 1348) from a French Canadian
family was found to have hand-motion vision at age 55.(C) Pedigrees and sequences of mutations of LCA families. Two different mutations were identified in these three families: all three
patients from the KKESH-060 family, c.322C/T (p.R108X); patient no. 12811 from the Dutch family, c.322C/T (p.R108X); patient
no. 1617 from the family with mid Eastern origin, c.961dupA (p.P321TfsX326).
(D) Pedigrees and sequences of mutations of juvenile RP families. Two different mutations were identified: patient no. 28608, c.1183C/Trican Journal of Human Genetics 84, 380–387, March 13, 2009 383
Figure 2. Color Photographs of the Retinas
of Two RP Patients with SPATA7 Mutations
(A) Retinal image of the right eye of a 55-year-
old male with juvenile RP and a homozygous
c.1546delA p.Q465fsX505 frameshift mutation
in SPATA7.
(B) Retinal photograph of the left eye of a
9-year-old femalewith20/20acuities, 5 visual
fields, and a homozygous p.R395X nonsense
mutation in SPATA7. The retinal appearance
shows narrow arterioles but normal-caliber
veins, normal color of the optic disc, a subtle grayish discoloration of the retina, and a faint hypopigmented diffuse perifoveal annulus.
There were no pigmentary changes.He reported seeing normally as a child and then declining,
developing night blindness and nystagmus. This patient
was found to have advanced retinal pigmentary degenera-
tion, with narrow arterioles, optic disc pallor, and a small
maculopathy on exam at age 55 years (Figure 2B). The
ERG was nondetectable, and the visual ﬁelds were reduced
to 5 with the V4e target.
Spata7 Is a Highly Conserved, Vertebrate-Speciﬁc
Protein Expressed in the Mature Retina
Human SPATA7 comprises 12 exons (Figure 1B) that
encode a protein of 599 amino acids. SPATA7 is conserved
from sea urchin to human but is absent in lower eukary-
otes, such as insects and fungi (Figure S4). A single-pass
transmembrane domain is predicted by the PSIPred
program (Figure 1B). However, no previously known func-
tional domains have been identiﬁed.
Studies of gene-expression proﬁles, including the use of
microarrays and databases of expressed sequence tags,
indicate that SPATA7 is expressed in the human retina.
We examined the expression pattern of Spata7 in the
mouse retina at several developmental stages, using both
mRNA ISH and IHC. Mouse retinas were stained at three
developmental time points, E16.5, P4, and P21, corre-
sponding to early, middle, and fully developed retinas.
On the basis of the ISH results, Spata7 is not detectable in
the E16.5 or P4 mouse retina (Figures 3A and 3B), suggest-
ing that Spata7 is not required for early retinal develop-
ment. In contrast, expression is observed in the P21
mature mouse retina, suggesting that Spata7 may be
involved in normal retinal function rather than develop-
ment (Figure 3C). Consistent with ISH results, little Spata7
protein is detected in the P4 mouse retina by IHC (Figures
3D–3F). In contrast, expression of Spata7 protein is
observed in multiple layers of the P21 retina, including
the ganglion cell and inner nuclear layers, and inner
segments of photoreceptors (Figures 3G–3L).
Discussion
It is interesting to note that mutations in SPATA7 cause
LCA and RP, two overlapping but distinct human retinal
diseases. A fascinating aspect of human retinal diseases is
the enormous heterogeneity in terms of both clinical384 The American Journal of Human Genetics 84, 380–387, Marchphenotypes and their underlying molecular mechanisms.
Undoubtedly complex genetic inheritance contributes to
this heterogeneity. For example, digenic triallelic inheri-
tance has been observed in some families segregating the
Bardet-Biedl phenotype, in which inheritance of a muta-
tion in a second gene is required for an individual who
has two mutations in the ﬁrst gene to exhibit a clinical
phenotype or to modify the severity of the primary pheno-
type.33 Another major cause for heterogeneity is differen-
tial severity of mutant alleles at a single locus, as is likely
in our study. We have isolated multiple loss-of-function
mutations in SPATA7 that cause either LCA or juvenile
RP. Consistent with the observation that LCA has a more
severe clinical phenotype than juvenile RP, the mutant
alleles associated with LCA are likely to be more severe
loss-of-function alleles than those associated with juvenile
RP. The two alleles found in our LCA patients are nonsense
mutations located in the middle of the SPATA7 coding
region (exons 5 and 8; Figure 1B). These two mutations
will probably cause relatively early protein truncations
and therefore are likely to be severe loss-of-function alleles
because of nonsense-mediated decay and destruction of
message.34,35 In contrast, the two mutations that we iden-
tiﬁed in the juvenile RP patients are located in the last two
exons of SPATA7. Because these two mutations are very
close to the C terminus of the protein, they will probably
cause only truncation of a small portion of the protein
product, although it is possible that the mutation in the
second-to-last exon could cause a reduction of SPATA7
mRNA levels as a result of nonsense-mediated decay.34,35
Therefore, our ﬁndings provide suggestive evidence of
a correlation between the severity of mutant alleles in
SPATA7 and the resulting clinical phenotype.
It is conceivable that many human diseases are caused
not only by coding mutations but by noncoding-region
mutations that may affect gene expression. For example,
the most prominent mutation in the LCA gene CEP290 is
an intron mutation that causes aberrant splicing of the
transcript.14 Our data suggest that the initial LCA3 family,
KKESH-019, probably carries a mutation outside of the
coding region of the SPATA7 gene rather than in other
genes in this locus. All genes within the critical region
deﬁned by the KKESH-019 family alone have been
sequenced, and no mutations were identiﬁed within13, 2009
exonic sequences in the KKESH-019 family. To identify
a disease-causing mutation in the KKESH-019 family, we
ﬁrst sequenced the 50 and 30 UTR regions of SPATA7, but
we found no change. Furthermore, to test for possible
chromosome rearrangements at the SPATA7 locus in this
family, we used tiling of 3 kb PCR amplicons to analyze
the entire SPATA7 locus, including about 50 kb beyond
the transcription unit, from an affected KKESH-019
patient, but we found no obvious changes compared to
WT. This result suggests that no major chromosomal rear-
rangements, insertions, or deletions are present at the
SPATA7 locus in the KKESH-019 family. However,
sequencing of these PCR products did identify several
changes, including single-nucleotide substitutions and
small insertions and deletions in the promoter region
and introns of SPATA7. Because RNA samples from the
KKESH-019 family are not available, we are not able to test
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Figure 3. Spata7 Is Expressed in the Adult Mouse Retina
(A–C) Section ISH with Spata7 riboprobes. (A) Spata7 is absent in
all layers of the E16.5 mouse eye. (B) Spata7 is absent in all layers
of the P4 mouse eye. (C) At P21, Spata7 is present in the ganglion
cell layer, the inner nuclear layer, and the inner segment of the
photoreceptors.
(D–F) Double immunostaining of Spata7 (red) and Rhodopsin
(green) shows that Spata7 is not expressed in the P4 mouse retina.
(G–I) Double immunostaining of Spata7 (red) and Rhodopsin
(green) in the P21 mouse retina demonstrates that Spata7 protein
is expressed in multiple cell layers of the retina.
(J–L) High-magnification images of photoreceptors reveals that
Spata7 expression is prominent in the inner segment and sparse
in the Rhodopsin-labeled outer segment. Abbreviations are as
follows: ONL, outer nuclear layer; IS, inner segment; INL, inner
nuclear layer; GCL, ganglion cell layer; RPE, retinal pigment epithe-
lium; OS, outer segment.The Amewhether these changes can indeed affect SPATA7 expres-
sion in the patients. Additional experiments will need to
be carried to determine whether any of these noncoding
changes cause defects in normal SPATA7 expression.
SPATA7 is a gene that was ﬁrst identiﬁed in human sper-
matocytes. On the basis of its expression pattern, SPATA7
may be involved in preparing chromatin in early meiotic
prophase nuclei for the initiation of meiotic recombina-
tion.36We found that in addition to its expression in testis,
Spata7 is expressed in multiple layers of the mature mouse
retina. On the basis of its expression pattern in the retina,
it would seem that SPATA7 is not a typical cilium protein,
despite its potential function in both sperm and retina.
Close examination of SPATA7 expression in the retina indi-
cates that the protein is not enriched at the junction
between the inner and outer segments of photoreceptor
cells, where the cilium is located. Rather, the protein shows
a uniform distribution in the cytoplasm of the inner
segment. Given this information, together with the rela-
tively late onset of SPATA7 expression in the retina, we
speculate that SPATA7 may be involved a novel pathway.
Additional studies need to be carried out to reveal the func-
tion of SPATA7.
In summary, we report the cloning of another LCA
disease gene, SPATA7. The LCA3 locus was ﬁrst mapped
to chromosome 14 more than 10 years ago, but the causal
gene had not been identiﬁed. Through the combination of
homozygosity mapping by SNP arrays and direct Sanger
sequencing of all positional candidate genes within the
LCA3 critical region, we identiﬁed SPATA7 as the disease-
causing gene. Given that we identiﬁed multiple mutations
in distinct ethnic groups, this gene appears to be an impor-
tant player in LCA and in other retinal diseases, such as
juvenile RP. As a gene that is linked to multiple human
diseases, SPATA7 offers opportunities for uncovering novel
insights into human pathogenesis.
Supplemental Data
Supplemental Data include four ﬁgures and two tables and can be
found with this article online at http://www.ajhg.org/.
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html?org¼Human&db¼hg18&hgsid¼120774634
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